Associated Papers
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2025
Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
Qin Y et al.
Renal Failure, 2024
Whole exome sequencing approach for identification of the molecular etiology in pediatric patients with hematuria.
Wu J et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2024
Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
da Silveira-Neto JN et al.
Diagnostic Pathology, 2021
Case Report: Lipoprotein Glomerulopathy Complicated by Atypical Hemolytic Uremic Syndrome.
Kollbrunner L et al.
Frontiers in Medicine, 2021
The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Wu H et al.
Journal of Atherosclerosis and Thrombosis, 2018
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
Matsunaga A et al.
Clinical and Experimental Nephrology, 2014
Select a paper to view details